24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
10/11/2015
Natura Bissé in the Barcelona Synchrotron Park
05/11/2015
Two Research Centers Awarded at the UAB University
28/10/2015
How ideas grow, the new Barcelona Synchrotron Park video
20/10/2015
Welcome to Barcelona
08/10/2015
Good News for Two PRUAB Spin-Offs
30/09/2015
BSC-CNS Director, Prof. Valero, Recipient of the Seymour Cray Computer Engineering Award